Key Metrics of The Ensign Group Inc.
Revenue$3.7B▲ 23.3% YoYFY 2023
Operating income$255M▼ 14.0% YoY
Net profit$209M▼ 6.8% YoY
Shareholders' equity$1.5B
Market cap$10.4BENSG · $179.06
Competitors10identified
About The Ensign Group Inc.
Sectors
Company details
- Founded
- 2007
- Listed
- Nasdaq: ENSG (since 2007)
Operational Areas of The Ensign Group Inc.
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameThe Ensign Group Inc.
TickerENSG
ExchangeNasdaq
CountryUnited States
SEC CIK0001125376
Listed since2007
IndustryHospital/Nursing Management
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Website—
US market & SEC filings
ENSG · Nasdaq · SEC CIK 0001125376
Last price · 03 Nov 2026
$179.06
−1.36%
Market cap$10.4B
P/E49.1On FY 2023 diluted EPS
Volume408,414
SectorHealth CareHospital/Nursing Management
Country · IPOUnited StatesListed 2007
ENSG share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of The Ensign Group Inc.
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.